Companies: 10,795·Total market cap: $144.5T
Miromatrix Medical Inc.

Miromatrix Medical Inc.

MIRONASDAQHealthcare
$3.39
+$0.02(+0.59%)
Market Cap$92951088
P/E Ratio
52W High$4.35
52W Low$0.906

Miromatrix Medical Inc. (MIRO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

miro · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Miromatrix Medical Inc. (MIRO) measures how much investors pay for each dollar of the company's trailing earnings. MIRO's current PE ratio of N/A is calculated by dividing its stock price of $3.39 by its TTM earnings per share of -$1.45.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
FY2025 est. EPS $-1.07
Based on 2 analysts
EPS (TTM)
-$1.45
TTM · diluted EPS
PEG Ratio
-0.12
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Miromatrix Medical Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Miromatrix Medical Inc.
Miromatrix Medical Inc.You
MIRO
$93MN/A-$1.45
Aadi Bioscience, Inc.
Aadi Bioscience, Inc.
AADI
$95MN/A-$0.03
Berkeley Lights, Inc.
Berkeley Lights, Inc.
BLI
$87MN/A-$1.42
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
CYT
$109MN/A-$1.25
HilleVax, Inc.
HilleVax, Inc.
HLVX
$105MN/A-$3.00
IGM Biosciences, Inc.
IGM Biosciences, Inc.
IGMS
$77MN/A-$3.24
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc.
IMDX
$165MN/A-$1.65

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-1.45
2021-12-31
FY2021
$-0.73
2020-12-31
FY2020
$-0.82
2019-12-31
FY2019
$-0.29

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Miromatrix Medical Inc. (MIRO) measures how much investors pay for each dollar of the company's trailing earnings. MIRO's current PE ratio of N/A is calculated by dividing its stock price of $3.39 by its TTM earnings per share of -$1.45.

PE Ratio = Stock Price ÷ EPS (TTM)
= $3.39 ÷ -$1.45 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MIRO pe ratio · 6 questions

MIRO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.39 and TTM EPS of -$1.45. Data sourced from Financial Modeling Prep via MIRO's SEC 10-K and 10-Q filings.

MIRO PE ratioWhat is MIRO PE ratioCurrent PE ratio of MIROMIRO PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Miromatrix Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09